GE HealthCare to Acquire Intelerad in $2.3B Deal
The acquisition is expected to broaden GE HealthCare’s cloud and AI imaging tools and extend its reach into outpatient workflows.
The acquisition is expected to broaden GE HealthCare’s cloud and AI imaging tools and extend its reach into outpatient workflows.
The FDA 510(k) pending Carestation 850 is designed to help anesthesia teams address growing clinical complexity, workflow demands, and sustainability goals.
The new Voluson Performance series features AI and automation tools designed to simplify exams and improve workflow efficiency.
The acquisition is expected to broaden GE HealthCare’s cloud and AI imaging tools and extend its reach into outpatient workflows.
The company has now accumulated over 100 authorizations for artificial intelligence in its medical technology portfolio.
Read MoreThe floor-mounted digital X-ray system automates in-room workflows and repetitive tasks to help improve throughput and reduce the technologist learning curve.
Read MoreFrom artificial intelligence-assisted troubleshooting to predictive platforms, vendors and end-users share what’s working—and what it takes to get there.
Read MoreWith disasters on the rise, HTM teams are relying on modern tools and coordinated planning to support smarter emergency response.
Read MoreThe Carestation anesthesia systems are being recalled due to a risk of ineffective ventilation in volume control mode, which could lead to serious injury or death.
Read MoreNew tracer Flyrcado (flurpiridaz F 18)—a PET myocardial perfusion imaging (MPI) agent developed for use in patients with known or suspected CAD—gains Medicare and commercial coverage.
Read More
New technologies include automated tumor burden software, compact cyclotron, and AI-powered SPECT/CT and PET/CT systems.